PHANES THERAPEUTICS
DEAD

Serial Number

87555473

Owner

Phanes Therapeutics,Inc.

Attorney

Alex Patel

Filing Date

Aug 3, 2017

Add to watchlist:

No watchlists yet
View on USPTO

PHANES THERAPEUTICS Trademark

Serial Number: 87555473

PHANES THERAPEUTICS is a trademark filed by Phanes Therapeutics,Inc. on August 3, 2017. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

Phanes Therapeutics,Inc. (12 trademarks)

9215 BROWN DEER ROAD, SUITE B
SAN DIEGO, CA 92121

Entity Type: 03

Trademark Details

Filing Date

August 3, 2017

Registration Date

Not Registered

Published for Opposition

January 2, 2018

Goods & Services

Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; Chemical preparations for pharmaceutical or medical purposes, namely, for viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Biological preparations for the treatment of cancer; Biological preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Ferments for pharmaceutical purposes; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical agents affecting metabolism; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Medical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Tumor suppressing agents; Clinical medical reagents; Anti-diabetic pharmaceuticals; Anti-cancer preparations; Cellular function activating agents for medical purposes

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Apr 5, 2021 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Apr 5, 2021 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 19, 2020 EXRA
SOU EXTENSION 5 GRANTED
Aug 18, 2020 EX5G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Aug 18, 2020 AITU
SOU EXTENSION 5 FILED
Aug 14, 2020 EXT5
SOU TEAS EXTENSION RECEIVED
Aug 14, 2020 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 13, 2020 EXRA
SOU EXTENSION 4 GRANTED
Feb 11, 2020 EX4G
SOU EXTENSION 4 FILED
Feb 11, 2020 EXT4
SOU TEAS EXTENSION RECEIVED
Feb 11, 2020 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 7, 2019 EXRA
SOU EXTENSION 3 GRANTED
Aug 5, 2019 EX3G
SOU EXTENSION 3 FILED
Aug 5, 2019 EXT3
SOU TEAS EXTENSION RECEIVED
Aug 5, 2019 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 14, 2019 EXRA
SOU EXTENSION 2 GRANTED
Feb 12, 2019 EX2G
SOU EXTENSION 2 FILED
Feb 12, 2019 EXT2
SOU TEAS EXTENSION RECEIVED
Feb 12, 2019 EEXT
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Nov 27, 2018 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Nov 27, 2018 COAR
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 17, 2018 EXRA
SOU EXTENSION 1 GRANTED
Jul 13, 2018 EX1G
SOU EXTENSION 1 FILED
Jul 13, 2018 EXT1
SOU TEAS EXTENSION RECEIVED
Jul 13, 2018 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Feb 27, 2018 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 2, 2018 NPUB
PUBLISHED FOR OPPOSITION
Jan 2, 2018 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 13, 2017 NONP
ASSIGNED TO LIE
Nov 27, 2017 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 15, 2017 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 15, 2017 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 14, 2017 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 14, 2017 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Nov 12, 2017 GNRN
NON-FINAL ACTION E-MAILED
Nov 12, 2017 GNRT
NON-FINAL ACTION WRITTEN
Nov 12, 2017 CNRT
ASSIGNED TO EXAMINER
Nov 3, 2017 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Aug 10, 2017 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 9, 2017 NWOS
NEW APPLICATION ENTERED
Aug 7, 2017 NWAP